Ascidian Therapeutics logo

Ascidian Therapeutics

Rewriting RNA

48 employees · est. 2020 · Boston, United States

VS
EdiGene Inc. logo

EdiGene Inc.

Edit the Code of Life, Creating Transformative Solutions for Serious Diseases.

46 employees · est. 2015 · Beijing, China

EdiGene Inc. is the older company (2020 vs 2015).

Side-by-Side Comparison

Ascidian Therapeutics EdiGene Inc.
Founded
2020 2015 older
Headquarters
Boston, United States Beijing, China
Employees
48 46
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care
Funding Stage
Series A Series B
Total Funding
$90.00M $180.04M
Funding Rounds
3 6
Services
RNA exon editing platform, Developing RNA-based medicines, Manufacturing partnership for RNA therapies Gene Editing Technologies, RNA Editing Solutions, Cell and Gene Therapies, Therapeutic Development Platforms, High-Throughput Genomic Screening
Target Customers
Patients with genetic diseases, Healthcare professionals, Biotechnology researchers Healthcare Providers, Biotech Researchers, Pharmaceutical Companies, Medical Practitioners, Patients with Genetic Disorders
Taxonomy
RNA Therapeutics, Gene Editing, Post-transcriptional Editing, Ophthalmology, Neurological Disorders, Neuromuscular Disorders, Rare Diseases, Functional Proteins, Exon Editing, Disease Treatment, Precision Medicine, Preclinical Programs, Therapeutic Innovation Gene Editing, Genetic Medicines, RNA Base Editing, Hematopoietic Stem Cell Editing, CAR-T Therapy, Genome Editing Technology, Molecular-Level Treatment, Gene Knockout, Gene Knock-in, Targeted Mutations, High Throughput Screening, Bioinformatics, Ex Vivo Gene Editing, In Vivo Gene Editing, Therapeutic Platforms
Website
ascidian-tx.com edigene.com
Ascidian Therapeutics logo

About Ascidian Therapeutics

Ascidian Therapeutics, founded in 2020, is a pioneering company in the Biotechnology and Health and Wellness industries, headquartered in the United States. Their slogan, "Rewriting RNA," encapsulates their innovative approach to disease treatment by focusing on RNA editing. By targeting exons at th...

EdiGene Inc. logo

About EdiGene Inc.

EdiGene Inc., founded in 2015, is a clinical-stage biotech company based in China, dedicated to innovating through gene-editing technologies. Their motto, "Edit the Code of Life, Creating Transformative Solutions for Serious Diseases," captures the essence of their mission in the Biotechnology and H...

We will tell you when either one moves

BounceWatch watches Ascidian Therapeutics and EdiGene Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ascidian Therapeutics and EdiGene Inc. — by email.

Frequently Asked Questions

Ascidian Therapeutics — Rewriting RNA. EdiGene Inc. — Edit the Code of Life, Creating Transformative Solutions for Serious Diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ascidian Therapeutics has raised $90.00M while EdiGene Inc. has raised $180.04M.
Ascidian Therapeutics and EdiGene Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ascidian Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ascidian Therapeutics on 9 Jun 2026, and EdiGene Inc. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy